Navigation Links
MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment
Date:8/4/2010

Investigators have identified a new mechanism that controls the number of hematopoietic stem cells cells that give rise to all blood and immune system cells. In a report in the online Early Edition of Proceedings of the National Academy of Sciences, researchers from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute identify a tiny RNA molecule that increases the number of these blood stem cells, an advance that may improve treatment of blood system cancers.

"This novel molecule raises blood stem cell numbers by suppressing the normal cell-death process," explains David Scadden, MD, director of the MGH Center for Regenerative Medicine and senior author of the report. "We've known that these non-coding RNAs can define what an immature cell will become, but none has previously been identified that can tell a blood system stem cell whether to live or die."

MicroRNAs short strands of RNA not involved in the production of proteins bind to and silence the expression of their target genes and play important roles in cellular development and differentiation, including the process by which hematopoietic stem cells (HSCs) mature into red or white blood cells. Since the process that controls the size of the HSC population is unknown, the researchers investigated whether microRNAs were involved. They found that loss of the enzyme Dicer, known to be essential to the generation of microRNAs, caused the death of HSCs, supporting the involvement of microRNAs in maintaining HSC levels.

Futher investigation identified a cluster of microRNAs present at enhanced levels in HSCs and showed that one of them, miRNA-125a, increased numbers of HSCs by protecting them from the cell-death process that normally limits cellular populations. The protective effects of miRNA-125a were only seen at the stem-cell level and may involve suppression of the cell-death protein Bak1.

A related PNAS study from researchers at California Institute of Technology, also released online, found that elevated levels of a related molecule called miRNA-125b in HSCs could lead to an aggressive form of leukemia in mice. "These molecules modify cellular numbers in ways that can be both beneficial and detrimental, so it will be important to understand the differences," Scadden explains.

"We're now looking at ways to expand the stem cell population to briefly turn on the anti-cell-death protection to overcome limited levels of stem cells that can restrict the use of stem cell transplantation for patients with blood system failure and blood-cell cancers. Accomplishing that could make life-saving stem cell transplants available to more patients," he adds. Scadden is the Gerald and Darlene Jordan Professor of Medicine at Harvard Medical School and co-director of the Harvard Stem Cell Institute.


'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Related medicine news :

1. Scientists identify microRNA as possible cause of chemotherapy resistance
2. Study links microRNA to shut-down of DNA-repair genes
3. Cancer cells show rewired, fragmented microRNA networks
4. IU research team discovers TB disease mechanism and molecule to block it
5. Tiny molecules may tell big story about cardiovascular disease risk
6. New Cancer-Fighting Strategy Focuses On Signaling Molecules
7. Small molecule with high impact
8. Sigma-Aldrich Reaches Agreement to Sell Pfizers Bioactive Small Molecule Compounds
9. Inflammation Molecule May Determine Fat Levels
10. Exploring the Davids and Goliaths of therapeutic molecules
11. ACS Webinar focuses on drug discovery process for small molecule therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... St. Louis, MO (PRWEB) , ... May 02, ... ... ROHO Inc., a division of Permobil, recently completed two groundbreaking studies that determined ... cushions and mattresses – are critical in the prevention of pressure injuries, which ...
(Date:5/2/2016)... ... 02, 2016 , ... Atlantic Information Services, Inc. (AIS) is pleased to announce ... Transform the Pharma Landscape .” CMS recently proposed a test of alternate payment models ... while preserving care provided to beneficiaries. The webinar will review the details of this ...
(Date:5/2/2016)... ... 2016 , ... The Evolve Paddle Board Company- which specializes in the production ... of their partnership with Yoloha Yoga- producers of high quality cork yoga mats. Together ... has seen a dramatic rise in popularity throughout the last few years. The makers ...
(Date:5/2/2016)... ... May 02, 2016 , ... Summit BHC ... the opening of Twin Lakes Recovery Center. Located east of Atlanta in ... state. The residential facility is set on 34 acres of beautiful, secluded ...
(Date:5/2/2016)... ... May 02, 2016 , ... Advanced Spine & Sport Medical ... Platelet Rich Plasma (PRP) injections. “These are becoming the ‘go-to’ treatment option for ... Advanced Spine & Sport Medical. “We are very excited to be able to ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016   Click here for supplemental information ... DPLO), the nation,s largest independent specialty pharmacy, announced ... to acquire Valley Campus Pharmacy, Inc., doing business ... specialty pharmacy that provides individualized patient care, based ... In 2015, TNH generated approximately $400 million in ...
(Date:4/28/2016)... -- Research and Markets has announced the ... 2016-2020" report to their offering.      ... global plastic surgery products market is expected to grow ... , ,The growing adoption of laser in aesthetics is ... market. Lasers are used to treat a broad range ...
(Date:4/28/2016)... TOKYO , April 28, 2016 /PRNewswire/ ... Ahuja , George Phillips und ... wachsenden Unternehmens    ArisGlobal®, ein ... Life Sciences, gab heute bekannt, dass neue ... wachsenden Unternehmens gestoßen sind, die vielfältige Erfahrungen ...
Breaking Medicine Technology: